Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-29

Clinical Trial Update: Switch of AndroidAPS to Commercially Available AID Systems [NA]

View source ↗

Summary

The trial reports switching from AndroidAPS to commercially available automated insulin delivery (AID) systems for type 1 diabetes. The current status is ACTIVE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Diabetes Mellitus, Type 1 | NA | Status: ACTIVE_NOT_RECRUITING